EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Reports U.S. Collaboration Partner Announces Journal of Infectious Diseases and Treatment Publishes Positive Aviptadil Data in High Comorbidity Critical COVID-19 Patients w/ Respiratory Failure
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous/Miscellaneous Relief Reports U.S. Collaboration Partner Announces Journal of Infectious Diseases and Treatment Publishes
Source: finanznachrichten.de